| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |